Cargando…
A study on quantitative structure–activity relationship and molecular docking of metalloproteinase inhibitors based on L-tyrosine scaffold
BACKGROUND: MMP-2 enzyme is a kind of matrix metalloproteinases that digests the denatured collagens and gelatins. It is highly involved in the process of tumor invasion and has been considered as a promising target for cancer therapy. The structural requirements of an MMP-2 inhibitor are: (1) a fun...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4423142/ https://www.ncbi.nlm.nih.gov/pubmed/25925871 http://dx.doi.org/10.1186/s40199-015-0111-z |
_version_ | 1782370158453456896 |
---|---|
author | Abbasi, Maryam Ramezani, Fatemeh Elyasi, Maryam Sadeghi-Aliabadi, Hojjat Amanlou, Massoud |
author_facet | Abbasi, Maryam Ramezani, Fatemeh Elyasi, Maryam Sadeghi-Aliabadi, Hojjat Amanlou, Massoud |
author_sort | Abbasi, Maryam |
collection | PubMed |
description | BACKGROUND: MMP-2 enzyme is a kind of matrix metalloproteinases that digests the denatured collagens and gelatins. It is highly involved in the process of tumor invasion and has been considered as a promising target for cancer therapy. The structural requirements of an MMP-2 inhibitor are: (1) a functional group that binds the zinc ion, and (2) a functional group which interacts with the enzyme backbone and the side chains which undergo effective interactions with the enzyme subsites. METHODS: In the present study, a QSAR model was generated to screen new inhibitors of MMP-2 based on L–hydroxy tyrosine scaffold. Descriptors generation were done by Hyperchem 8, DRAGON and Gaussian98W programs. SPSS and MATLAB programs have been used for multiple linear regression (MLR) and genetic algorithm partial least squares (GA-PLS) analyses and for theoretical validation. Applicability domain of the model was performed to screen new compounds. The binding site potential of all inhibitors was verified by structure-based docking according to their binding energy and then the best inhibitors were selected. RESULTS: The best QSAR models in MLR and GA-PLS were reported, with the square correlation coefficient for leave-one-out cross-validation (Q(2)(LOO)) larger than 0.921 and 0.900 respectively. The created MLR and GA-PLS models indicated the importance of molecular size, degree of branching, flexibility, shape, three-dimensional coordination of different atoms in a molecule in inhibitory activities against MMP-2. The docking study indicated that lipophilic and hydrogen bonding interactions among the inhibitors and the receptor are involved in a ligand-receptor interaction. The oxygen of carbonyl and sulfonyl groups is important for hydrogen bonds of ligand with Leu82 and Ala83. R(2) and R(3) substituents play a main role in hydrogen bonding interactions. R(1) is sited in the hydrophobic pocket. Methylene group can help a ligand to be fitted in the lipophilic pocket, so two methylene groups are better than one. The Phenyl group can create a π-π interaction with Phe86. CONCLUSIONS: The QSAR and docking analyses demonstrated to be helpful tools in the prediction of anti-cancer activities and a guide to the synthesis of new metalloproteinase inhibitors based on L-tyrosine scaffold. |
format | Online Article Text |
id | pubmed-4423142 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-44231422015-05-08 A study on quantitative structure–activity relationship and molecular docking of metalloproteinase inhibitors based on L-tyrosine scaffold Abbasi, Maryam Ramezani, Fatemeh Elyasi, Maryam Sadeghi-Aliabadi, Hojjat Amanlou, Massoud Daru Research Article BACKGROUND: MMP-2 enzyme is a kind of matrix metalloproteinases that digests the denatured collagens and gelatins. It is highly involved in the process of tumor invasion and has been considered as a promising target for cancer therapy. The structural requirements of an MMP-2 inhibitor are: (1) a functional group that binds the zinc ion, and (2) a functional group which interacts with the enzyme backbone and the side chains which undergo effective interactions with the enzyme subsites. METHODS: In the present study, a QSAR model was generated to screen new inhibitors of MMP-2 based on L–hydroxy tyrosine scaffold. Descriptors generation were done by Hyperchem 8, DRAGON and Gaussian98W programs. SPSS and MATLAB programs have been used for multiple linear regression (MLR) and genetic algorithm partial least squares (GA-PLS) analyses and for theoretical validation. Applicability domain of the model was performed to screen new compounds. The binding site potential of all inhibitors was verified by structure-based docking according to their binding energy and then the best inhibitors were selected. RESULTS: The best QSAR models in MLR and GA-PLS were reported, with the square correlation coefficient for leave-one-out cross-validation (Q(2)(LOO)) larger than 0.921 and 0.900 respectively. The created MLR and GA-PLS models indicated the importance of molecular size, degree of branching, flexibility, shape, three-dimensional coordination of different atoms in a molecule in inhibitory activities against MMP-2. The docking study indicated that lipophilic and hydrogen bonding interactions among the inhibitors and the receptor are involved in a ligand-receptor interaction. The oxygen of carbonyl and sulfonyl groups is important for hydrogen bonds of ligand with Leu82 and Ala83. R(2) and R(3) substituents play a main role in hydrogen bonding interactions. R(1) is sited in the hydrophobic pocket. Methylene group can help a ligand to be fitted in the lipophilic pocket, so two methylene groups are better than one. The Phenyl group can create a π-π interaction with Phe86. CONCLUSIONS: The QSAR and docking analyses demonstrated to be helpful tools in the prediction of anti-cancer activities and a guide to the synthesis of new metalloproteinase inhibitors based on L-tyrosine scaffold. BioMed Central 2015-04-29 /pmc/articles/PMC4423142/ /pubmed/25925871 http://dx.doi.org/10.1186/s40199-015-0111-z Text en © Abbasi et al.; licensee BioMed Central. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Abbasi, Maryam Ramezani, Fatemeh Elyasi, Maryam Sadeghi-Aliabadi, Hojjat Amanlou, Massoud A study on quantitative structure–activity relationship and molecular docking of metalloproteinase inhibitors based on L-tyrosine scaffold |
title | A study on quantitative structure–activity relationship and molecular docking of metalloproteinase inhibitors based on L-tyrosine scaffold |
title_full | A study on quantitative structure–activity relationship and molecular docking of metalloproteinase inhibitors based on L-tyrosine scaffold |
title_fullStr | A study on quantitative structure–activity relationship and molecular docking of metalloproteinase inhibitors based on L-tyrosine scaffold |
title_full_unstemmed | A study on quantitative structure–activity relationship and molecular docking of metalloproteinase inhibitors based on L-tyrosine scaffold |
title_short | A study on quantitative structure–activity relationship and molecular docking of metalloproteinase inhibitors based on L-tyrosine scaffold |
title_sort | study on quantitative structure–activity relationship and molecular docking of metalloproteinase inhibitors based on l-tyrosine scaffold |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4423142/ https://www.ncbi.nlm.nih.gov/pubmed/25925871 http://dx.doi.org/10.1186/s40199-015-0111-z |
work_keys_str_mv | AT abbasimaryam astudyonquantitativestructureactivityrelationshipandmoleculardockingofmetalloproteinaseinhibitorsbasedonltyrosinescaffold AT ramezanifatemeh astudyonquantitativestructureactivityrelationshipandmoleculardockingofmetalloproteinaseinhibitorsbasedonltyrosinescaffold AT elyasimaryam astudyonquantitativestructureactivityrelationshipandmoleculardockingofmetalloproteinaseinhibitorsbasedonltyrosinescaffold AT sadeghialiabadihojjat astudyonquantitativestructureactivityrelationshipandmoleculardockingofmetalloproteinaseinhibitorsbasedonltyrosinescaffold AT amanloumassoud astudyonquantitativestructureactivityrelationshipandmoleculardockingofmetalloproteinaseinhibitorsbasedonltyrosinescaffold AT abbasimaryam studyonquantitativestructureactivityrelationshipandmoleculardockingofmetalloproteinaseinhibitorsbasedonltyrosinescaffold AT ramezanifatemeh studyonquantitativestructureactivityrelationshipandmoleculardockingofmetalloproteinaseinhibitorsbasedonltyrosinescaffold AT elyasimaryam studyonquantitativestructureactivityrelationshipandmoleculardockingofmetalloproteinaseinhibitorsbasedonltyrosinescaffold AT sadeghialiabadihojjat studyonquantitativestructureactivityrelationshipandmoleculardockingofmetalloproteinaseinhibitorsbasedonltyrosinescaffold AT amanloumassoud studyonquantitativestructureactivityrelationshipandmoleculardockingofmetalloproteinaseinhibitorsbasedonltyrosinescaffold |